Gene · 3113
NIH grants1,839
NIH grants whose papers are about the gene, through NIH's grant-paper links.
941 to 960 of 1,839
Download this page as JSON| Grant | Title | HLA-DPA1 papers | Newest fiscal year |
|---|---|---|---|
| R24HG010032 | Services to support the OBO foundry standards | 1 | 2019 |
| R33AR073042 | Dissecting autoimmune cellular and molecular networks in vitiligo | 1 | 2019 |
| R41AI142919 | Rapid high-resolution typing of Human Leukocyte Antigen genes by nanopore sequencing for transplantation | 1 | 2019 |
| R56AG064877 | Genetic Architecture of Alzheimer's disease Proteinopathies | 1 | 2019 |
| R61NS115161 | Generation and characterization of a mouse model exhibiting beta-amyloidosis and tauopathy with nuclear depletion of TDP-43 | 1 | 2019 |
| RF1AG059717 | Translating SHIP1 Genetics to Generate a Novel Alzheimers Pharmacologic Agent | 1 | 2019 |
| RF1AG061127 | Building blood based DNA methylation signatures for AD that are reflective of CNS changes | 1 | 2019 |
| S10OD026799 | Illumina NovaSeq 6000 High Throughput DNA Sequencer for Emory University | 1 | 2019 |
| U01AI115520 | Determinants of Outcome and Recurrent Infections in Melioidosis | 1 | 2019 |
| U01CA186145 | Non-invasive evaluation of indeterminate pulmonary nodules | 1 | 2019 |
| U01CA199215 | Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts | 1 | 2019 |
| U01HG008673 | Genomic Medicine at Northwestern: Discovery and Implementation | 1 | 2019 |
| U19AI109662 | Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic | 1 | 2019 |
| U24AI118672 | An integrated multiplexed genomic assay for low input clinical samples1 | 1 | 2019 |
| UG3HL145266 | 1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study | 1 | 2019 |
| UH2AR067685 | UPITT Rheumatoid Arthritis Combined Center (UPITT RACC) | 1 | 2019 |
| UM1HL098123 | Genetics of conotruncal defects and associated neurodevelopmental outcomes | 1 | 2019 |
| UM1HL098147 | The Genomic Basis of Congenital Heart Disease and Neurodevelopmental Outcomes | 1 | 2019 |
| UM1HL098162 | Genetics and genomics of congenital heart disease and associated neurodevelopmental abnormalities | 1 | 2019 |
| ZIAES103316 | Toxicological Assessments for the National Toxicology Program | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/grants?page=48